DiabetesSeriesLive

CME Presentations

Diabetic Retinopathy


Presentations

  • CME
    0.5

    The Clinical Impact of Diabetic Retinopathy: The Ophthalmologist’s Challenge

    Speakers:Andrew A. Moshfeghi, MD, MBA, Associate Professor of Clinical Ophthalmology
    Richard Beaser, MD, Senior Physician; Medical Director of Continuing Medical Education
    Timothy J. Murtha, MD, Assistant Professor of Ophthalmology

    Duration: 30 minutes

    Presented on: November 1, 2017

  • CME
    0.5

    Research Update in Diabetic Retinopathy and Macular Edema: Impact on Clinical Care

    Speakers:Andrew A. Moshfeghi, MD, MBA, Associate Professor of Clinical Ophthalmology
    Richard Beaser, MD, Senior Physician; Medical Director of Continuing Medical Education
    Timothy J. Murtha, MD, Assistant Professor of Ophthalmology

    Duration: 30 minutes

    Presented on: November 1, 2017


Speakers


CME Information

Diabetic Retinopathy: Advances Impacting Diabetes Eye Care and Preservation of Vision

Presented by Joslin Diabetes Center in Joint Providership with PlatformQ Health Education, LLC

ACKNOWLEDGEMENT These activities are supported by an educational grant from Genentech.

TUITION Complimentary

ACCREDITATION STATEMENT The activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Joslin Diabetes Center and PlatformQ Health Education, LLC. Joslin Diabetes Center is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS Live Internet Activities Joslin Diabetes Center designates these live activities for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

Enduring Material Joslin Diabetes Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION Live Internet Activities Wednesday, November 1, 2017, from 2:00 PM EST – 2:30 PM EST •The Clinical Impact of Diabetic Retinopathy: The Ophthalmologist's Challenge Wednesday, November 1, 2017, from 2:30 PM EST – 3:00 PM EST •Research Update in Diabetic Retinopathy and Macular Edema: Impact on Clinical Care

Enduring Material The enduring material will be available from November 1, 2017 – May 1, 2018.

LEARNING OBJECTIVES At the conclusion of these activities, participants will be able to:

The Clinical Impact of Diabetic Retinopathy: The Ophthalmologist's Challenge
Describe the pathophysiology, presentation, and natural history of DR and DME, while emphasizing the importance of early and routine monitoring
Identify the evolving spectrum of therapeutic interventions currently available for the various stages of DR and DME, including the evolving role of anti-VEGF treatments
Select methods to optimize the coordination of care among general ophthalmologists and ophthalmologists specializing in retinal treatments
Research Update in Diabetic Retinopathy and Macular Edema: Impact on Clinical Care
List key findings from recently published studies that have impacted the treatment of DME and DR
Identify how specific aspects of the care of DR and DME have identified limitations in the treatment of advanced DR
Select methods to optimize the coordination of care among general ophthalmologists and ophthalmologists specializing in retinal treatments

INTENDED AUDIENCE Primary Audience: General ophthalmologists and retinal specialists

METHOD OF PARTICIPATION There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.

HARDWARE/SOFTWARE REQUIREMENTS Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURES As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning and/or CME advisory committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning and CME advisory committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services, with the exception of nonprofit or government organizations and non–healthcare–related companies, which are exempt. Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected. If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of Joslin Diabetes Center. The faculty and planning committee members for this program have disclosed the following:

Faculty

  • Dr. Richard S. Beaser*†, Senior Staff Physician and Medical Director of CME, Joslin Diabetes Center, has no relevant financial relationships with regard to this activity.
  • Andrew A. Moshfeghi, MD, MBA, Associate Professor of Clinical Ophthalmology, Director of Clinical Trials, Director of the Vitreoretinal Surgery Fellowship Program and Director of the Medical Retina Fellowship Program, USC Roski Eye Institute, Keck School of Medicine, University of Southern California, receives grant/research support from Regeneron, is a consultant for Regeneron, Genentech, Allergan, Visunex and Spark Therapeutics, and is stockholder with Visunex and Optistent
  • Timothy J. Murtha, MD, Assistant Professor of Ophthalmology, Harvard Medical School, Joslin Diabetes Center/Beetham Eye Institute, has no relevant financial relationships with regard to this activity.

Planning Committee

  • Agnes Yang, MD, Medical Director, PlatformQ Health Education, has no relevant financial relationships
  • Karen Greb-Murphy, Senior Program Manager, PlatformQ Health Education, has no relevant financial relationships

Joslin CME Advisory Committee

  • Jerry Cavallerano, OD, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships.
  • Nuha El Sayed, MD, Staff Physician and Medical Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.
  • Erin Kelly, CDE, Adult Diabetes Educator, Joslin Diabetes Center, is a contract pump trainer for Medtronic, Tandem, Omnipod and Animas.
  • Melinda Maryniuk, CDE, Director, Clinical Programs, Joslin Diabetes Center, has no relevant financial relationships.
  • Lyle Mitzner, MD, Staff Physician, Joslin Diabetes Center, is a consultant for Conversa Health
  • Kavita Seetharaman, MD, Staff Physician, Joslin Diabetes Center, has no relevant financial relationships
  • Alissa Segal, Pharm D, CDE, CDTC, FCCP, Clinical Pharmacist, Joslin Diabetes Center, is a consultant for Lilly and Boehringer Ingelheim.
  • Robert C. Stanton, MD, Chief of Nephrology, Joslin Diabetes Center, has no relevant financial relationships
  • Elena Toschi, MD, Staff Physician, Joslin Diabetes Center, has no relevant financial relationships.

* also on the Planning committee † also on the CME Advisory Committee

CONTACT INFORMATION Please send content inquiries to: cme@joslin.harvard.edu. For technical problems with the site or issues with your CME Certificate, please contact DiabetesSeriesLive at 877-394-1306 or at Support@DiabetesSeriesLive.com.

DISCLAIMERS (if applicable): The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material. The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Joslin Diabetes Center, DiabetesSeriesLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.